follows; 1.1 Sales of Biodiesel, Edible oil Refined Glycerine, Raw material and By-product ▪ For the year 2022, The sales volume decreased by 10.58% and the revenue from Biodiesel business decrease by

significant decreasing of diesel consumption in 2Q2020. In addition, rising of refined glycerine price and sales volume also affected to a higher methyl ester business sales revenue due to growing of refined

volume in 1Q2020 by 22,346 tons or 28% , resulted from the official announcement of B10 biodiesel as the mandatory diesel. Although, sales revenue of refined glycerine, by-product of methyl ester and fatty

/ Refined Glycerine Vessel operating Total Sale and service Other income Total revenues Revenues from sales and services 6,431.59 0.00 6,431.59 6.83 6,438.42 Cost of sales and services (5,890.19) 0.00

of Biodiesel, Edible oil Refined Glycerine, Raw material and By-product For 1st quarter of 2022, the Company’s revenue from sales of biodiesel, edible oil and by-products was increased by Baht 891.68

) Biodiesel Edible oil Refined glycerine Byproduct Vessel operating Total Sale and service Other income Total revenues Revenues from sales and services 1,404.30 0.00 1,404.30 1.40 1,405.70 Cost of sales and

of 2021 (Unit: Million Baht) Biodiesel /Edible oil Refined glycerine /Raw material & Byproduct Other income Total revenues Revenues from sales and services 1,514.32 1.40 1,515.72 Cost of sales and

2019 for crude glycerine used as raw material in production of refined glycerine. Besides, part of the loss was also caused by loss on impairment of investment in subsidiary (AIL) of 20.75 million Baht

has decreased by 6.30% despite total hospital income from general patients increased 8.69% compared with the same period of last year. This is mainly due to the medical-service-fee adjustment caused by

Refined Glycerine Vessel operating Total Sale and service Other income Total revenues Revenues from sales and services 1,820.91 0.00 16.22 4.88 1,842.01 1.55 1,843.56 Cost of sales and services (1,640.05